Biosimilar Retacrit® in the Treatment of Chemotherapy-induced Anaemia in Oncology and Haematology
NCT ID: NCT02158169
Last Updated: 2015-07-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2167 participants
OBSERVATIONAL
2012-06-30
2014-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Biosimilar Retacrit™ (Epoetin Zeta) in the Treatment of Chemotherapy-Induced Symptomatic Anaemia in Haematology and Oncology
NCT01626547
An Observational Study to Predict the Response of Erythropoietin Treatment in Participants With Cancer Related Anemia Receiving Chemotherapy
NCT01736215
Observatory of the Prescription of Erythropoietin as Treatment of Anemia Induced by Chemotherapy or Allograft Conditioning Among the Patients With a Haematological Malignancy
NCT02860598
Search for Predictive Markers of Efficacy of ESAs in Patients With Non-myeloid Malignancies or Myelodysplastic Syndrome
NCT01546337
Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With Cancer
NCT00482716
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients for whom the oncologist or hematologist has decided the initiation of an epoetin alpha biosimilar treatment (Retacrit®) for anemia.
* Patients informed about the computer processing of their medical data and their right of access and correction.
Exclusion Criteria
* Patients who have been transfused within the previous month.
* Patients who are hypersensitive to erythropoietin or one of its excipients.
* Patients participating or having participated in the previous month in a clinical trial in the field of anaemia in oncology.
* Patients refusing to participate in the observational study.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospira, now a wholly owned subsidiary of Pfizer
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hélène ALBRAND, MD
Role: STUDY_DIRECTOR
Hospira, now a wholly owned subsidiary of Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hopital Louis Pasteur
Colmar, Alsace, France
CH Emile Muller
Mulhouse, Alsace, France
CAC Paul Strauss
Strasbourg, Alsace, France
Chu Hopital Civil
Strasbourg, Alsace, France
MEDIPOLE
Aix-les-Bains, Auvergne-Rhône-Alpes, France
CHRA
Annecy, Auvergne-Rhône-Alpes, France
Clinique CONVERT
Bourg-en-Bresse, Auvergne-Rhône-Alpes, France
Ch Chambery
Chambéry, Auvergne-Rhône-Alpes, France
Chu Grenoble
Grenoble, Auvergne-Rhône-Alpes, France
Ch Valence
Valence, Auvergne-Rhône-Alpes, France
Chu Rennes
Rennes, Basse Normandie, France
CHU SUD
Rennes, Basse Normandie, France
Clinique St Laurent
Rennes, Basse Normandie, France
Chp St Greg
Saint-Grégoire, Basse Normandie, France
Ch St Malo
St-Malo, Basse Normandie, France
CHG William MOREY
Chalon S/s, Bourgogne-Franche-Comté, France
CHU du BOCAGE
Dijon, Bourgogne-Franche-Comté, France
Clinique St Faron
Meaux, Champagne, France
Cac Jean Godinot
Reims, Champagne, France
Hopital St Quentin
Saint-Quentin, Champagne, France
Hopital Troyes
Troyes, Champagne, France
Clinique Pasteur
Évreux, Haute Normandie, France
CH Jacques Monod
Montivilliers, Haute Normandie, France
CHG
Alès, Languedoc, France
CHG
Carcassonne, Languedoc, France
Chu St Eloi
Montpellier, Languedoc, France
CHU Caremeau
Nîmes, Languedoc, France
Ch Du Pays D'Aix
Aix-en-Provence, Marseille, France
Clinique Rambot
Aix-en-Provence, Marseille, France
Ch Duffaut
Avignon, Marseille, France
Chu Timone
Marseille, Marseille, France
Fondation Saint Joseph
Marseille, Marseille, France
Hopital A.Pare
Marseille, Marseille, France
IPC
Marseille, Marseille, France
Chu Estaing
Clermont, Massif Central, France
Chu Gabriel Montpied
Clermont, Massif Central, France
Pole Sante Republique
Clermont, Massif Central, France
Clinique Vitalia Desertines
Montluçon, Massif Central, France
CHR
Roanne, Massif Central, France
Icl St Etienne
Saint-Etienne, Massif Central, France
CHG Cahors
Cahors, Midi Pyrennees, France
CHG St Gaudens
Saint-Gaudens, Midi Pyrennees, France
Clinique de l'Ormeau
Tarbes, Midi Pyrennees, France
CHU Purpan
Toulouse, Midi Pyrennees, France
Clinique Pasteur
Toulouse, Midi Pyrennees, France
Inst. Claudius Regaud
Toulouse, Midi Pyrennees, France
Clinique des Bonnettes
Arras, Nord, France
CH Boulogne-sur-Mer
Boulogne, Nord, France
Centre Oscar Lambret
Lille, Nord, France
Clinique des Dentellieres
Valenciennes, Nord, France
Chi Frejus - St Raphael
Fréjus, Paca, France
Clinique Belvédère
Nice, Paca, France
CH Sainte Musse
Toulon, Paca, France
H.I.A Saint Anne
Toulon, Paca, France
Victor Dubos
Argenteuil, Paris Nord, France
Clinique Ste Marie
Osny, Paris Nord, France
Saint Antoine
Paris, Paris Nord, France
Saint Louis
Paris, Paris Nord, France
TENON
Paris, Paris Nord, France
Hpt Rene Dubos
Pontoise, Paris Nord, France
BEAUJON
Clichy, Paris Ouest, France
Hopital Mignot
Le Chesnay, Paris Ouest, France
Hopital Franco Britannique
Levallois-Perret, Paris Ouest, France
Hopital Des Courses
Maisons-Laffitte, Paris Ouest, France
HARTMANN
Neuilly/seine, Paris Ouest, France
Hopital Foch
Suresnes, Paris Ouest, France
Ico Angers
Angers, Pays de la Loire Region, France
Ch Le Mans
Le Mans, Pays de la Loire Region, France
Victor Hugo
Le Mans, Pays de la Loire Region, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Synergy
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.